Medical Device | January 10, 2024
Bruker acquires Tornado Spectral Systems to expand biopharma PAT product portfolio
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology
Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
NEIAFMR to be developed as the national hub for folk medicine
If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients
Subscribe To Our Newsletter & Stay Updated
